Skip to main content
Equibles

ACADIAN ASSET MANAGEMENT LLC

Position in NERV — Minerva Neurosciences, Inc.

CIK 916542 Boston, MA
Back to NERV Full portfolio

Position in NERV

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$28,721
-$13,806 QoQ
Shares Held
4,767
-54.9% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NERV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $732,389,014 across 168 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 1,664,999 $188,744,286
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,440 $98,170,137
3 IMCR
Immunocore Holdings plc
 1,209,894 $38,414,134
4 RIGL
Rigel Pharmaceuticals Inc
 591,686 $23,146,756
5 EXEL
Exelixis, Inc.
 421,444 $22,930,768
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 42,122 $20,923,261
7 TBPH
Theravance Biopharma, Inc.
 1,174,910 $19,973,470
8 PRTA
Prothena Corp Public Ltd Co
 2,010,645 $19,684,214

All Filings in NERV

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $28,721 4,767
2025-12-31 $42,527 10,579
2025-09-30 $36,660 17,416
2025-06-30 $29,955 17,416
2025-03-31 $29,607 17,416
2024-12-31 $38,698 17,416
2024-09-30 $46,500 17,416
2024-06-30 $55,579 17,423
2024-03-31 $44,951 17,423
2023-12-31 $107,151 17,423
2023-09-30 $120,218 17,423
2023-06-30 $196,171 21,463
2023-03-31 $45,345 28,341
2022-12-31 $45,062 28,341
2022-09-30 $274,444 29,734
2022-06-30 $731,788 221,084
2022-03-31 $1,468,008 1,768,685
2021-12-31 $1,416,716 1,768,685
2021-09-30 $2,976,240 1,710,483
2021-06-30 $4,137,095 1,783,231
2021-03-31 $5,085,515 1,741,615
2020-12-31 $4,001,034 1,709,844
2020-09-30 $5,422,520 1,705,195
2020-06-30 $3,298,493 913,710
2020-03-31 $1,130,519 187,794